Publications by authors named "Andrew Catchpole"

Claim this Profile
H
Human Challenge Trial of a Nucleoside-Modified Messenger Ribonucleic Acid Influenza Vaccine.
Kelly A Lindert, Alex Mann, Anita Geevarughese, Teresa Hauguel, Sarah Mirza, Andrew P Catchpole

NEJM Evid· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection.
Helen R Wagstaffe, Ryan S Thwaites, Jasmin K Sidhu, Rik G H Lindeboom, Lorenz Kretschmer, Andrew Catchpole

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and Safety of Aerosolized Influenza Virus Challenge in Humans Using Two Modern Delivery Systems.
Nadine Rouphael, Ralph Tanios, Jessica Traenkner, Matthew D Pauly, Nishit Shetty, Andrew P Catchpole

J Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction for Shetty et al., "Influenza virus infection and aerosol shedding kinetics in a controlled human infection model".
Nishit Shetty, Meredith J Shephard, Nicole C Rockey, Hollie Macenczak, Jessica Traenkner, Andrew P Catchpole

J Virol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled human influenza infection reveals heterogeneous expulsion of infectious virus into air.
Nahara Vargas-Maldonado, Nishit Shetty, Lucas M Ferreri, Matthew D Pauly, Kayle Patatanian, Andrew Catchpole

medRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of HEX17, a Novel Broad-Spectrum Antiviral Drug, in a Controlled Human Infection Model of Influenza Challenge.
Geoff Kitson, Marion Byford, Lindsey Cass, David Howat, Brigitte Köhn, Andrew Catchpole

Infect Dis Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Aerosol Inoculation of Dose-Escalated Seasonal Influenza H3N2 Virus in Controlled Human Infection Model.
Nadine Rouphael, Ralph Tanios, Jessica Traenkner, Matthew D Pauly, Nishit Shetty, Andrew P Catchpole

medRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus.
Mickie H Cheng, Alex J Mann, Brian M Maas, Tian Zhao, Melissa Bevan, Andrew P Catchpole

Pulm Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus.
Mickie H Cheng, Alex J Mann, Brian M Maas, Tian Zhao, Melissa Bevan, Andrew P Catchpole

Pulm Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infections.
Joshua Rosenheim, Rishi K Gupta, Clare Thakker, Tiffeney Mann, Lucy C K Bell, Andrew Catchpole

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in memory and cognition during the SARS-CoV-2 human challenge study.
William Trender, Peter J Hellyer, Ben Killingley, Mariya Kalinova, Alex J Mann, Andrew P Catchpole

EClinicalMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults.
Helen R Wagstaffe, Ryan S Thwaites, Arnold Reynaldi, Jasmin K Sidhu, Richard McKendry, Andrew Catchpole

Sci Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.
Rik G H Lindeboom, Kaylee B Worlock, Lisa M Dratva, Masahiro Yoshida, David Scobie, Andrew Catchpole

Nature· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection.
Astrid Marchal, Elizabeth T Cirulli, Iva Neveux, Evangelos Bellos, Ryan S Thwaites, Andrew Catchpole

HGG Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study.
Susan Jackson, Julia L Marshall, Andrew Mawer, Raquel Lopez-Ramon, Stephanie A Harris, Andrew Catchpole

Lancet Microbe· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.
Rik G H Lindeboom, Kaylee B Worlock, Lisa M Dratva, Masahiro Yoshida, David Scobie, Andrew Catchpole

Nature· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adults.
Jia Yao Phuah, Brian M Maas, Aimin Tang, Ying Zhang, Luzelena Caro, Andrew P Catchpole

Biomed Pharmacother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of association between HLA and asymptomatic SARS-CoV-2 infection.
Astrid Marchal, Elizabeth T Cirulli, Iva Neveux, Evangelos Bellos, Ryan S Thwaites, Andrew Catchpole

medRxiv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study.
Jie Zhou, Anika Singanayagam, Niluka Goonawardane, Maya Moshe, Fiachra P Sweeney, Andrew P Catchpole

Lancet Microbe· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemic.
Maria Piggin, Emma Smith, Peter Mankone, Leah Ndegwa, Diane Gbesemete, Andrew P Catchpole

Epidemics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study.
Beate Schmoele-Thoma, Agnieszka M Zareba, Qin Jiang, Mohan S Maddur, Rana Danaf, Andrew Catchpole

N Engl J Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.
Ben Killingley, Alex J Mann, Mariya Kalinova, Alison Boyers, Niluka Goonawardane, Andrew P Catchpole

Nat Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis.
Brian M Maas, Jos Lommerse, Nele Plock, Radha A Railkar, S Y Amy Cheung, Andrew P Catchpole

EBioMedicine· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic.
Garth Rapeport, Emma Smith, Anthony Gilbert, Andrew Catchpole, Helen McShane

N Engl J Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process.
Andrew P Catchpole, Daniel J Fullen, Nicolas Noulin, Alex Mann, Anthony S Gilbert

BMC Res Notes· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis